ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 662,30
-0,58%
Dow Jones
39 112,16
-0,76%
DAX
18 177,62
-0,90%
Brent Oil
84,585
0,48%
Bitcoin
61 741,35
-0,10%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Rain Oncology Inc (RAIN)

  7. Rain Oncology Inc (RAIN) Actualités

RAIN

Rain Oncology (RAIN)

Rain Oncology Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RAIN
DateHeureSourceTitreSymboleSociété
05/02/202412h41Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RAINRain Oncology Inc
31/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RAINRain Oncology Inc
26/01/202422h58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
26/01/202422h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
26/01/202422h32Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:RAINRain Oncology Inc
26/01/202415h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
26/01/202415h19Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
26/01/202415h13Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
03/01/202420h57PR Newswire (US)Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law FirmNASDAQ:RAINRain Oncology Inc
27/12/202315h27Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RAINRain Oncology Inc
27/12/202315h20Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:RAINRain Oncology Inc
14/12/202312h06Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:RAINRain Oncology Inc
09/11/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RAINRain Oncology Inc
12/09/202311h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
11/08/202311h45PR Newswire (US)RAIN SHAREHOLDER ALERT: Jakubowitz Law Reminds Rain Shareholders of a Lead Plaintiff Deadline of September 12, 2023NASDAQ:RAINRain Oncology Inc
06/07/202311h45PR Newswire (US)INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of an Investigation and Potential Class Action Lawsuit - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
30/06/202311h45PR Newswire (US)RAIN FRAUD ALERT: Jakubowitz Law is Investigating Rain Oncology Inc. in Connection with Potential Violations of Federal Securities LawsNASDAQ:RAINRain Oncology Inc
10/03/202323h22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RAINRain Oncology Inc
09/03/202322h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RAINRain Oncology Inc
03/03/202323h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RAINRain Oncology Inc
14/02/202323h22Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RAINRain Oncology Inc
14/02/202321h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RAINRain Oncology Inc
18/11/202218h35TipRanksJonesTrading Reaffirms Their Buy Rating on Rain Therapeutics (RAIN)NASDAQ:RAINRain Oncology Inc
11/11/202217h25TipRanksJonesTrading Keeps Their Buy Rating on Rain Therapeutics (RAIN)NASDAQ:RAINRain Oncology Inc
10/11/202222h52Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RAINRain Oncology Inc
10/11/202222h09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RAINRain Oncology Inc
04/11/202213h00GlobeNewswire Inc.Rain Therapeutics Announces $50 Million Registered Offering of Common StockNASDAQ:RAINRain Oncology Inc
04/11/202211h07Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:RAINRain Oncology Inc
20/09/202214h25TipRanksH.C. Wainwright Sticks to Their Buy Rating for Rain Therapeutics (RAIN)NASDAQ:RAINRain Oncology Inc
12/09/202214h15TipRanksRain Therapeutics (RAIN) Gets a Buy from JonesTradingNASDAQ:RAINRain Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:RAIN

Dernières Valeurs Consultées

CRTO
DYDXUSD
dYdX
HUOB
ICPUSDT
Internet Computer
TG
T7AA
Teva Pharmaceutical Fina...
LSE
FRAN
Franchise Brands
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés